DCBO

DCBO

USD

Docebo Inc. Common Shares

$31.870+0.170 (0.536%)

Reaalajas hind

Tehnoloogia
Software - Application
Kanada

Hinnagraafik

Põhinäitajad

Turunäitajad
Ettevõtte fundamentaalnäitajad
Kauplemisstatistika

Turunäitajad

Avatud

$31.700

Kõrge

$32.374

Madal

$31.700

Maht

0.01M

Ettevõtte fundamentaalnäitajad

Turukapitalisatsioon

966.0M

Tööstusharu

Software - Application

Riik

Canada

Kauplemisstatistika

Keskmine maht

0.09M

Börs

NMS

Valuuta

USD

52 nädala vahemik

Madal $26Praegune $31.870Kõrge $53.86

Tehisintellekti analüüsiaruanne

Viimati uuendatud: 18. apr 2025
Tehisintellekti loodudAndmeallikas: Yahoo Finance, Bloomberg, SEC

[DCBO: Docebo Inc. Common Shares]: Checking the Pulse - What's Next?

Stock Symbol: DCBO Generate Date: 2025-04-18 16:20:31

Alright, let's take a look at Docebo (DCBO). For folks who aren't glued to stock tickers all day, Docebo is in the learning software game – think online training platforms, especially using AI. So, what's the story lately?

Recent News Buzz: Mostly Good Vibes, But a Little Head-Scratching

The news feed for Docebo is actually looking pretty upbeat. We've got analysts at big firms like Morgan Stanley and Needham saying "Buy" or "Overweight." That's generally a good sign – these are the folks who dig deep into company numbers. Needham even kept their price target at $42, and Morgan Stanley, while lowering theirs a bit to $41, still thinks the stock should go up from where it is now.

What's got them feeling positive? A big part seems to be Docebo diving headfirst into AI. They just unveiled an "AI-First Learning Platform" with some fancy new features. Plus, they got a "Diamond" award from Brandon Hall Group, which sounds like a big deal in their industry – basically a stamp of approval for their learning platform.

Now, there's a tiny wrinkle. Morgan Stanley did lower their price target slightly. It's not a huge drop, but it suggests maybe they're a little less enthusiastic than before, even though they still recommend buying. Could be just fine-tuning their expectations, or maybe a slight concern in the back of their minds. We'll need to watch if other analysts follow suit.

Price Check: Bumpy Ride Lately

Looking at the stock price over the last month or so, it's been a bit of a rollercoaster, mostly downhill. Back in late January/early February, DCBO was hanging around the $42-$43 range. Then, it started to slide, hitting a low point around $27-$28 in early March. Recently, it's bounced back a little, hovering around $29.

So, the overall trend has been downwards. However, it seems to have found some footing around the $29 mark recently. The AI prediction models are hinting at a slight upward nudge in the next few days – nothing dramatic, but maybe a sign that the bleeding has stopped, at least for now.

Current price is around $29. Compared to where it was a month ago, that's a drop. But compared to the recent lows, it's a bit of a recovery. The AI's predictions suggest maybe this little bounce could continue.

Outlook & Strategy Ideas: Cautious Optimism?

Putting it all together, what's the takeaway? It feels like a mixed bag, but with a potential for things to get a bit brighter.

Near-term leaning: Maybe leaning towards "hold" or even cautiously "accumulate." Why? The news is generally positive, especially around their AI push. Analysts are still bullish. The price has taken a hit, but seems to be stabilizing. And AI models are predicting a slight uptick.

Potential Entry Consideration: If you were thinking about getting into DCBO, around the current price of $29 might be an area to watch. It seems to be acting as a bit of a support level recently. If it holds, and the positive news keeps flowing, there could be room for it to move up. However, be cautious. The recent downtrend is still a factor.

Potential Exit/Stop-Loss Consideration: On the upside, if the stock does start to climb, maybe look at the $30-$31 range as a potential area to take some profits, at least initially. For risk management, a stop-loss somewhere below the recent lows, perhaps around $26-$27, could make sense. This is just to protect yourself if the stock decides to resume its downward slide.

Company Context: Remember, Docebo is in the software business, specifically learning platforms. Their big push into AI is clearly a key focus right now, and the market seems to be reacting somewhat positively to that. Keep an eye on news related to their AI platform adoption and any further analyst updates.

In short: Docebo has had a rough patch price-wise, but the underlying news and future AI predictions aren't all doom and gloom. It's a situation that warrants careful watching. It's not a screaming "buy" signal right now, but it's also not necessarily time to panic and sell if you already own it. Patience and careful observation might be the best strategy for now.


Disclaimer: Please remember, this is just an analysis based on the information provided and is intended for informational purposes only. It is not financial advice. Investing in the stock market involves risk, and you could lose money. Always do your own thorough research and consider consulting with a qualified financial advisor before making any investment decisions.

Seotud uudised

BusinessWire

Docebo Achieves FedRAMP® Moderate Authority to Operate (ATO), Expanding Ability to Provide Secure Learning Capabilities to US Federal Agencies

Docebo Inc. (NASDAQ:DCBO, TSX:DCBO) ("Docebo" or the "Company"), a leading learning platform provider with a foundation in artificial intelligence (AI) and innovation, today announced that it is now

Vaata rohkem
Docebo Achieves FedRAMP® Moderate Authority to Operate (ATO), Expanding Ability to Provide Secure Learning Capabilities to US Federal Agencies
Analyst Upgrades

Morgan Stanley Maintains Overweight on Docebo, Lowers Price Target to $41

Morgan Stanley analyst Josh Baer maintains Docebo with a Overweight and lowers the price target from $43 to $41.

Vaata rohkem
Morgan Stanley Maintains Overweight on Docebo, Lowers Price Target to $41
BusinessWire

Docebo to Host First Quarter Fiscal 2025 Conference Call

Docebo Inc. (NASDAQ:DCBO, TSX:DCBO) ("Docebo" or the "Company"), a leading learning platform provider with a foundation in artificial intelligence (AI) and innovation, announced today that it will hold a

Vaata rohkem
Docebo to Host First Quarter Fiscal 2025 Conference Call
Analyst Upgrades

Needham Reiterates Buy on Docebo, Maintains $42 Price Target

Needham analyst Ryan MacDonald reiterates Docebo with a Buy and maintains $42 price target.

Vaata rohkem
Needham Reiterates Buy on Docebo, Maintains $42 Price Target
BusinessWire

Docebo Unveils AI-First Learning Platform at Docebo Inspire 2025

Debuts Product & Technology Innovations to Showcase Transformation into AI-First Learning Platform Announces Harmony, Docebo's L&D Agentic Marketplace & Co-pilot Docebo Inc. (NASDAQ:DCBO, TSX:DCBO),

Vaata rohkem
Docebo Unveils AI-First Learning Platform at Docebo Inspire 2025

Tehisintellekti ennustusBeta

Tehisintellekti soovitus

Tõusev

Uuendatud kell: 28. apr 2025, 02:21

LangevNeutraalneTõusev

60.8% Kindlus

Risk ja kauplemine

Riskitase3/5
Keskmine risk
Sobib
Agressiivne
Kauplemisjuhend

Sisenemispunkt

$31.98

Võta kasum

$32.47

Peata kahjum

$28.65

Põhitegurid

DMI näitab langustrendi (ADX:21.0, +DI:5.5, -DI:10.4), mis viitab ettevaatlikkusele
Praegune hind on tugitasemele ($31.98) äärmiselt lähedal, mis viitab tugevale ostuvõimalusele
Kauplemismaht on 2.8x keskmisest (1,464), mis näitab märkimisväärset ostuhuvi
MACD -0.0710 on signaalijoone -0.0301 all, mis viitab langevale ristumisele

Püsi kursis

Määrake hinnateavitused, hankige tehisintellekti analüüsi uuendusi ja reaalajas turuuudiseid.